Cargando…
Macrolides in critically ill patients with Middle East Respiratory Syndrome
OBJECTIVES: Macrolides have been reported to be associated with improved outcomes in patients with viral pneumonia related to influenza and other viruses, possibly because of their immune-modulatory effects. Macrolides have frequently been used in patients with Middle East Respiratory Syndrome (MERS...
Autores principales: | Arabi, Yaseen M., Deeb, Ahmad M., Al-Hameed, Fahad, Mandourah, Yasser, Almekhlafi, Ghaleb A., Sindi, Anees A., Al-Omari, Awad, Shalhoub, Sarah, Mady, Ahmed, Alraddadi, Basem, Almotairi, Abdullah, Al Khatib, Kasim, Abdulmomen, Ahmed, Qushmaq, Ismael, Solaiman, Othman, Al-Aithan, Abdulsalam M., Al-Raddadi, Rajaa, Ragab, Ahmad, Al Harthy, Abdulrahman, Kharaba, Ayman, Jose, Jesna, Dabbagh, Tarek, Fowler, Robert A., Balkhy, Hanan H., Merson, Laura, Hayden, Frederick G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7110878/ https://www.ncbi.nlm.nih.gov/pubmed/30690213 http://dx.doi.org/10.1016/j.ijid.2019.01.041 |
Ejemplares similares
-
Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome
por: Alraddadi, Basem M., et al.
Publicado: (2019) -
Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study
por: Shalhoub, Sarah, et al.
Publicado: (2018) -
Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study
por: Arabi, Yaseen M, et al.
Publicado: (2020) -
Critically ill patients with diabetes and Middle East respiratory syndrome: a multi-center observational study
por: Jose, Jesna, et al.
Publicado: (2021) -
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2018)